✦ LIBER ✦

A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease

✍ Scribed by J Jankovic; C Hunter

Book ID: 117751767
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 104 KB
Volume: 8
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(01)00040-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rotigotine transdermal patch in early Pa

Rotigotine transdermal patch in early Parkinson's disease: A randomized, double-blind, controlled study versus placebo and ropinirole

✍ Nir Giladi; Babak Boroojerdi; Amos D. Korczyn; David J. Burn; Carl E. Clarke; An 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract Rotigotine is a new, non‐ergot dopamine agonist formulated in a transdermal delivery system. The present study was to investigate the efficacy and safety of the rotigotine transdermal patch in the treatment of early Parkinson's disease. Patients (n = 561) were randomized to rotigotine,

Levodopa improves physical fatigue in Pa

Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study

✍ Jau-Shin Lou; Greg Kearns; Theodore Benice; Barry Oken; Gary Sexton; John Nutt 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract We quantitatively investigated the effect of carbidopa/levodopa (25/100) on physical fatigue during finger tapping and force generation in a double‐blind, placebo‐controlled crossover study. Parkinson's disease (PD) subjects were randomly assigned to carbidopa/levodopa or placebo for Vi

Donepezil for dementia in Parkinson's di

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

✍ Ravina, B 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 90 KB

Double-blind placebo-controlled study of

Double-blind placebo-controlled study of velnacrine in Alzheimer's disease

✍ Frank P. Zemlan; Michael Keys; Ralph W. Richter; Richard L. Strub 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 672 KB

2.257 A double blind placebo controlled

2.257 A double blind placebo controlled study of modafinil for Parkinson's disease related fatigue

✍ H. Tyne; J. Brooks; J. Taylor; S. Vinjamuri; G. Baker; M. Steiger 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Botulinum toxin type A for drooling in P

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

✍ Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To investigate the safety and efficacy of botulinum toxin type A (BoNTX) treatment to reduce sialorrhea in Parkinson's disease (PD), a double-blind, randomized, placebo-controlled study enrolled 32 PD patients complaining of excessive drooling. Patients received either 50 U Botox in each parotid gla